Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Avitide closes Series E round

Executive Summary

Avitide Inc. (affinity purification solutions for biopharma) raised an undisclosed amount in its Series E financing led by Sands Capital Ventures, which adds a board member and was joined by Mithril Capital Management, Polaris Partners, NeoMed Management, OrbiMed Advisors, and Borealis Ventures. The company says the funds will support ongoing operations with the goal of becoming profitable by 2019.
Deal Industry
  • Pharmaceuticals
  • Services
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Synthesis Technologies, Production Processes
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register